
Ozempic Could Change Births in America
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
More babies could be born because of Ozempic as it can improve fertility and has led to surprise pregnancies, experts have told Newsweek.
There have been multiple reports of an "Ozempic babies" phenomenon after women reported becoming pregnant on the drug, even while on birth control in some cases.
Last month, the United Kingdom's Medicines and Healthcare products Regulatory Agency, an executive agency of the Department of Health and Social Care, urged women on Ozempic and other similar weight loss drugs to make sure they are on effective birth control if they do not want to conceive.
Professor Alexander Miras, a clinical professor of medicine who has led studies on how weight loss interventions influence live birth rates in women with polycystic ovary syndrome (PCOS), told Newsweek that this is happening because women with obesity often have no periods and do not routinely use contraception.
Photo-illustration by Newsweek/GettyCanva
"Medications for obesity cause significant weight loss and this can rapidly improve fertility, thus the unwanted pregnancies," he said.
Similarly, reproductive endocrinologist Dr. Patricia Jimenez, from WashU Medicine, told Newsweek: "For people with irregular menstrual cycles, weight loss has been shown to increase ovulation and therefore pregnancy."
"Weight loss also can improve semen parameters," she added.
However, Jimenez stressed that these drugs "are not fertility medications, and for people struggling with infertility, the best option is to talk with a specialist about fertility treatment."
Meanwhile Karin Hammarberg, a senior research fellow at Monash University who has authored several pieces on "Ozempic babies," said that unwanted pregnancies from weight loss drugs could be a cause for concern.
"They will cause some unexpected and unplanned pregnancies, which is concerning since we don't know how this drug might affect the growing fetus," she told Newsweek.
While a lot is still unknown about Ozempic, its ability to affect fertility may have an impact on the number of births in America, which is, along with most other countries, struggling with declining birth rates.
Could Ozempic Lead to an Increase in Birth Rates?
"We may indeed observe an increase in birth rates because a previously untreated population of women with infertility will now have more access to effective pharmacotherapy for obesity that can rapidly improve their fertility," Miras said.
While Hammarberg agrees that weight loss drugs could add a number of births to the total, she does not believe it "will make any difference to birth rates at a population level."
Jimenez said "we need more data to understand whether these medications will have a significant impact on birth rates" as "there is no evidence that weight loss increases live birth rates in people with regular ovulatory cycles or with fertility treatments."
America's fertility rates are projected to average 1.6 births per woman over the next three decades, according to the Congressional Budget Office's latest forecast released this year.
This number is well below the replacement level of 2.1 births per woman required to maintain a stable population without immigration.
With financial struggles and worries often cited as reasons for people having fewer children, solutions often focus on calling for policies that include making child care, health care, housing and education more accessible.
Others have focused on cultural impacts. For example, Norway is a global leader in parental leave and child care policies, but is still facing a birth rate crisis. Its Birth Rate Committee has pointed largely to cultural changes, including the fact that fewer people are having their first child before the age of 30 because lower rates of couples in their 20s are staying together.
Dr. Jonathan Sher, founding partner of Scotland's Coalition for Healthier Pregnancies, Better Lives and the former deputy director of the Queen's Nursing Institute Scotland, is one of several who have urged countries to look at fertility and pregnancies as a way of tackling birth rates.
He previously wrote that remedies linked to finances are "built on the assumption that people of childbearing potential are increasingly choosing not to become parents."
Sher said that focusing on achieving healthier fertility and pregnancies could save multiple "unhappy endings" which includes miscarriages, stillbirths, therapeutic terminations, very premature deliveries, harm to the mother's health and/or her future reproductive life, as well as babies born with life-limiting birth defects.
"These are pregnancies intended to be full term and produce healthy babies who will grow up to become net assets to their economies and societies," Sher said.
Although saving all of these pregnancies would be impossible, "many of these unwelcome outcomes could, and should, have been prevented through robust, universal, effective policies and practices under the umbrella of preconception and interconception health, education and care," he said.
How Does Ozempic Work?
Ozempic is an injectable prescription drug that was developed to manage blood sugar levels in patients with Type 2 diabetes. It has surged in popularity because of how it assists weight loss.
It is based on a naturally occurring human hormone called glucagon-like peptide 1 (GLP-1), which plays an important role in regulating appetite and blood sugar levels. Its active ingredient is a molecule called semaglutide, which mimics the structure of this GLP-1 hormone and activates its receptors.
In doing so, semaglutide induces feelings of fullness while delaying the emptying of the stomach, making users feel less hungry and therefore less likely to overeat.
Jamie Winn, of the online pharmacy Universal Drugstore, previously told Newsweek that "Ozempic may interfere with the absorption of oral contraceptives, which can reduce their effectiveness and lead to an unwanted pregnancy."
"If you are taking Ozempic and an oral contraceptive, it is recommended that you also use a barrier method of birth control such as a condom," Winn added. "Another option is to switch to a long-acting reversible contraceptive such as an IUD."
But, like Jimenez, Winn said: "While Ozempic may increase fertility, caution should be taken if you get pregnant while on this medication. There is not enough information on the use of Ozempic by pregnant women, and there were adverse outcomes in animal studies. Pregnant rats that were given Ozempic had an increased rate of fetal death and birth defects.
"Because it can take up to six weeks for Ozempic to be cleared from your body, it is recommended that you stop Ozempic at least two months before you plan on getting pregnant," Winn said. "If you become pregnant or think you are pregnant while on Ozempic, stop taking the medication and call your health care provider immediately."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
20 minutes ago
- Newsweek
Alert Issued Urging People to Monitor Themselves for 'Unusual Fatigue'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A slew of air quality alerts was issued across the Upper Midwest on Thursday, advising some residents to seek medical attention if they experience symptoms such as "unusual fatigue." Newsweek reached out to the Wisconsin Department of Natural Resources (DNR) by email for comment. Why It Matters Residents across Wisconsin faced potentially hazardous air quality on Thursday due to a mass of wildfire smoke drifting from Canada. With fine particulate matter (PM2.5) levels reaching thresholds deemed unhealthy for sensitive groups, state officials responded by issuing advisories for more than a dozen counties. The move underscored the ongoing public health risk posed by recurring wildfire smoke events, which have grown increasingly common in recent years as large blazes persist in Canadian provinces. Vulnerable individuals—especially those with heart or respiratory conditions, children, and older adults—have been warned that even brief exposure can trigger symptoms or exacerbate underlying health issues. What To Know The Wisconsin DNR issued an air quality advisory beginning at 6 a.m. Thursday, impacting the counties of Ashland, Barron, Bayfield, Burnett, Chippewa, Douglas, Dunn, Iron, Pepin, Pierce, Polk, Price, Rusk, Sawyer, St. Croix, Vilas, and Washburn. Burning forest fire in British Columbia in Kootenay National Park. Burning forest fire in British Columbia in Kootenay National Park. James_Gabbert/Getty According to state officials, the Air Quality Index (AQI) for PM2.5—tiny particles capable of penetrating deep into the lungs—was forecast to reach levels classified as "Unhealthy for Sensitive Groups" (USG) and, in some areas, "Unhealthy." The advisory stemmed from dense smoke originating in ongoing Canadian wildfires, particularly from Saskatchewan and Manitoba, that migrated south into the Upper Midwest. The smoke plume was expected to reach the Duluth/Superior area between 6 and 9 a.m. and gradually move southeast, extending impacts throughout the day and possibly into the weekend. As meteorological conditions change, the alert area was scheduled to be updated in response to real-time monitoring and predictive models. The official alert recommended that residents—especially those with preexisting lung or heart disease, asthma, young children, and older adults—take precautionary measures. These include limiting the intensity and duration of outdoor activities, moving activities indoors if possible, and staying alert for any new or worsening symptoms. For all residents, staying indoors and keeping windows closed remained a key precaution while smoke persists in the area. Health officials urged residents to monitor themselves for symptoms associated with poor air quality. Key symptoms to watch for included: Coughing Shortness of breath Throat irritation Unusual fatigue Chest discomfort Heart palpitations People with asthma were advised to follow their asthma action plans and keep quick-relief inhalers readily available. Those with heart disease were instructed to contact their health care providers if symptoms such as palpitations, shortness of breath, or unexpected fatigue developed. The advisory also encouraged all residents, including healthy individuals, to keep outdoor activities shorter and less intense, and to go inside if any symptoms present. What People Are Saying Air quality alert issued in Wisconsin: "People with heart disease: Symptoms such as palpitations, shortness of breath, or unusual fatigue may indicate a serious problem. If you have any of these, contact your health care provider." A Wisconsin DNR webpage about wildfire smoke: "Larger and more frequent wildfires are a growing public health concern, as wildfire smoke from larger fires can travel and impact air quality hundreds or even thousands of miles away and cause a wide range of health impacts based on a person's sensitivity to pollutants and the amount of pollutants in the air." What Happens Next The air quality advisory remained in effect through Thursday with a possibility for extension or adjustment depending on updated smoke projections and AQI readings. As southerly winds are forecast to return over the weekend, state officials anticipated that smoke may be pushed farther north, allowing air quality to improve gradually in majority of the state. However, lingering smoke impacts could require advisories to remain in effect for certain regions.


Newsweek
2 hours ago
- Newsweek
US Birth Rate Plunges to New Low — CDC
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The United States' total fertility rate fell to a record low in 2024, dipping below 1.6 children per woman, according to new federal data released Thursday by the Centers for Disease Control and Prevention (CDC). This marks a significant demographic milestone for a country that once stood apart among developed nations for maintaining a replacement-level birth rate of around 2.1 children per woman. The U.S. fertility rate, once buoyed by post-World War II baby booms and comparatively high birth rates among younger women, has been steadily declining for nearly two decades. Many women are delaying motherhood or opting out of having children altogether — a trend now bringing American fertility rates closer to those of Western Europe. World Bank data confirms this alignment with long-standing European demographic patterns. The toes of a baby are seen at a hospital in McAllen, Texas, on Wednesday, July 29, 2020. The toes of a baby are seen at a hospital in McAllen, Texas, on Wednesday, July 29, 2020. Associated Press Despite concern in some political circles, experts suggest the falling birth rate reflects broader cultural and economic shifts, rather than an imminent population crisis. "We're seeing this as part of an ongoing process of fertility delay," said Leslie Root, a fertility and population policy researcher at the University of Colorado Boulder. "We know that the U.S. population is still growing, and we still have a natural increase — more births than deaths." Nevertheless, declining fertility has captured the attention of policymakers. In response to the trend, the Trump administration has advocated for several pro-natal measures, including an executive order aimed at expanding access to and reducing the cost of in vitro fertilization. The administration has also floated the idea of "baby bonuses" to incentivize family growth. But critics argue that these proposals are unlikely to reverse the trend without addressing deeper structural issues. Karen Guzzo, director of the Carolina Population Center at the University of North Carolina, said many young people are simply not ready to start families due to financial uncertainty, lack of support systems, and late marriages. "Worry is not a good moment to have kids," she explained. "And that's why birth rates in most age groups are not improving." Asked about the administration's initiatives, Guzzo was skeptical: "The things that they are doing are really symbolic and not likely to budge things for real Americans." She emphasized that lasting change would require more comprehensive policies, such as paid parental leave and affordable child care. The CDC's updated figures for 2024 show that the total fertility rate dropped from 1.621 in 2023 to 1.599. That statistic is derived from a more detailed analysis of birth certificates and replaced earlier provisional estimates. Interestingly, the new report also shows a 1% increase in overall births — roughly 33,000 more babies — compared to 2023, bringing the total to just over 3.6 million. However, this does not reflect a higher birth rate. The CDC clarified that the discrepancy stemmed from recalculated population estimates, which now account for an increase in women of childbearing age due to immigration. "That's plausible," Root said. "As the total population of women of childbearing age grew due to immigration, it offset small increases in births to women in those age groups." Ultimately, both experts agree the U.S. faces a complex demographic shift shaped by economics, policy, and evolving personal choices. This article includes reporting by the Associated Press.


Newsweek
2 hours ago
- Newsweek
Treatments From Llama's Brains Can Help People With Schizophrenia
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Antibodies from llamas could be used to create a new generation of schizophrenia treatments that can effectively target the brain, rather than just reducing symptoms. This is the promise of a study led by scientists at the Institute of Functional Genomics in Montpellier, France, who have designed a new "nanobody", made from llama antibody fragments, that can activate a receptor involved in regulating neural activity. The new molecule can be injected into veins or muscles and has demonstrated its ability to cross the protective 'blood–brain barrier' and effectively reach receptors in brain cells. This makes the new nanobody more effective than the antibodies currently used in schizophrenia treatments, according to the researchers. It is also biodegradable and associated with limited side effects. "There is an urgent need for efficient and innovative therapies to treat brain disorders such as psychiatric and neurodegenerative diseases," the study authors wrote. "Immunotherapies have proved to be efficient in many medical areas, but have not been considered to treat brain diseases due to the poor brain penetration of immunoglobulins." (Immunoglobulins are antibodies critical to the body's immune response.) Although current treatments for schizophrenia—usually a combination of personalized talking therapies and medicines—can provide support and more day-to-day independence, the researchers say that they have little effect on the cognitive deficits impacting those living with the condition. Affecting around one percent of Americans, schizophrenia can cause a range of different psychological symptoms related to thought processes, perceptions, emotional responsiveness, and social interactions. People may have so-called episodes, during which their symptoms are more severe, followed by periods when they experience few or no symptoms. A smiling fluffy llama face staring into the camera. A smiling fluffy llama face staring into the camera. Display/Getty Images "Patients have strong difficulties concentrating, leading to many cognitive problems," paper author and CNRS molecular biologist Jean-Philippe Pin told Newsweek. According to Pin, medications currently given to patients with schizophrenia "treat the symptoms well, but less the cognitive deficits." Some 'antipsychotics' currently used can also cause side effects in some people. In the new study, the therapeutic effect of the nanobodies was evaluated in two animal models of schizophrenia. The treatment was seen to correct cognitive defects and improve the animal's brain function from the first injection—with the beneficial effect lasting for at least one week. Pin explains that no llamas were harmed in the study—in fact, he added, "nowadays one can identify nanobodies from synthetic libraries generated in vitro, based on llama nanobody sequences. No need for the llama any more, and faster!" It is not clear at present whether this new llama-derived therapy is effective enough to stand alone, but early signs appear promising. "In humans obviously we don't know [yet], but in mice yes, it is sufficient to treat most deficits of schizophrenia," said Pin. However, as schizophrenia is a chronic condition, any such human-approved treatment would need to be taken for life. A graphic illustration representing colourful nanobodies targeting a protein found in the COVID-19 virus. A graphic illustration representing colourful nanobodies targeting a protein found in the COVID-19 virus. selvanegra/Getty Images Further clinical studies are now required to demonstrate that the nanobodies' ability to correct cognitive deficits could be safely and effectively applied to humans. "For development as a therapeutic tool, more safety and bioavailability studies are needed. Production of large quantities of high quality must be set up to start human studies. For these two possibilities, either a company takes up our project or we find investors to create a startup company," Pin explained. For now, the research confirms the potential of the nanobodies as a new therapeutic strategy acting on the brain, with scope for their use to eventually include the treatment of other neurological illnesses too. "Our results establish a proof of concept that nanobodies can target brain receptors, and pave the way for nanobody-based therapeutic strategies for the treatment of brain disorders," the researchers wrote. Do you have a tip on a health story that Newsweek should be covering? Do you have a question about schizophrenia? Let us know via health@ Reference Oosterlaken, M., Rogliardo, A., Lipina, T., Lafon, P.-A., Tsitokana, M. E., Keck, M., Cahuzac, H., Prieu-Sérandon, P., Diem, S., Derieux, C., Camberlin, C., Lafont, C., Meyer, D., Chames, P., Vandermoere, F., Marin, P., Prézeau, L., Servent, D., Salahpour, A., ... Rondard, P. (2025). Nanobody therapy rescues behavioural deficits of NMDA receptor hypofunction. Nature.